Merck has set the list price for a drug that received approval from the FDA.

The entities involved

• FDA →
  • Generic medicine services are seeking approval for launch from the FDA.Mon 17:49
  • A company is seeking FDA feedback on its NEO212 program, with a meeting scheduled at the FDA's White Oak campus.Mon 14:56
• Merck →

  public company in Indonesia

  • Eli Lilly, Novo Nordisk, and Merck are currently competing in the highly competitive GLP-1 obesity market.Sat 17:22
  • Merck will share clinical trial results at the American Academy of Ophthalmology (AAO) meeting.Fri 18:13

Related events

• Merck's stock price increased following positive drug performance involving Summit Therapeutics.Sep 3
• The FDA is monitoring drug industry practices and pricing, utilizing studies published by JAMA.Sep 10
• Merck is seeking FDA approval for its drug Winrevair, based on data from the ZENITH, HYPERION, and Stellar studies.Jun 8
• A product was launched in the U.S. market following FDA involvement.Sep 8
• Merck faces sales challenges in China while simultaneously seeking FDA approval for new drugs.Sep 10